{"id":283963,"date":"2024-05-10T09:00:00","date_gmt":"2024-05-10T13:00:00","guid":{"rendered":"https:\/\/www.noom.com\/?post_type=b2b_resource&#038;p=283963"},"modified":"2025-03-17T15:40:34","modified_gmt":"2025-03-17T19:40:34","slug":"bridging-the-glp-1-care-gap-for-better-outcomes-and-roi","status":"publish","type":"b2b_resource","link":"https:\/\/www.noom.com\/uk\/health\/resources\/webinars\/bridging-the-glp-1-care-gap-for-better-outcomes-and-roi\/","title":{"rendered":"Bridging the GLP-1 Care Gap for Better Outcomes and ROI"},"content":{"rendered":"\n<p>While GLP-1 medications have shown much promise for weight loss, they can leave people in worse health than before, especially when medications are not used according to the drug label: as an adjunct to a diet and exercise program.&nbsp;<\/p>\n\n\n\n<p>Yet, our healthcare system isn\u2019t well-equipped to support patients during and after a GLP-1 course of care. Primary care clinicians, who typically have little training in obesity, are getting inundated with patients\u2019 requests for GLP-1s, but they generally lack the time to manage and support patients\u2019 use of the drugs over months\u2014hence fueling the GLP-1 care gap.&nbsp;<\/p>\n\n\n\n<p>Without the right support system, patients risk losing a significant amount of muscle mass, strength, and bone density, which can result in a lowered resting metabolic rate, worsening insulin resistance, and weight regain after stopping the medication. The impact? Poor health outcomes for patients and exacerbated costs for payers.<\/p>\n\n\n\n<p>Join our expert panel as we delve into:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The science behind GLP-1s and muscle loss<\/li>\n\n\n\n<li>Why GLP-1 success, from both an outcomes and cost savings perspective, depends on tailored behavior change<\/li>\n\n\n\n<li>How Noom\u2019s GLP-1 Companion can help close the care gap for your GLP-1 population<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>While GLP-1 medications have shown much promise for weight loss, they can leave people in worse health than before, especially when medications are not used according to the drug label: as an adjunct to a diet and exercise program.&nbsp; Yet, our healthcare system isn\u2019t well-equipped to support patients during and after a GLP-1 course of [&hellip;]<\/p>\n","protected":false},"author":85,"featured_media":284016,"menu_order":0,"template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_searchwp_excluded":"","footnotes":""},"b2b-content-type":[442],"b2b-topic":[],"class_list":["post-283963","b2b_resource","type-b2b_resource","status-publish","has-post-thumbnail","hentry","b2b-content-type-webinars"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.noom.com\/uk\/wp-json\/wp\/v2\/b2b_resource\/283963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.noom.com\/uk\/wp-json\/wp\/v2\/b2b_resource"}],"about":[{"href":"https:\/\/www.noom.com\/uk\/wp-json\/wp\/v2\/types\/b2b_resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.noom.com\/uk\/wp-json\/wp\/v2\/users\/85"}],"version-history":[{"count":0,"href":"https:\/\/www.noom.com\/uk\/wp-json\/wp\/v2\/b2b_resource\/283963\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.noom.com\/uk\/wp-json\/wp\/v2\/media\/284016"}],"wp:attachment":[{"href":"https:\/\/www.noom.com\/uk\/wp-json\/wp\/v2\/media?parent=283963"}],"wp:term":[{"taxonomy":"b2b-content-type","embeddable":true,"href":"https:\/\/www.noom.com\/uk\/wp-json\/wp\/v2\/b2b-content-type?post=283963"},{"taxonomy":"b2b-topic","embeddable":true,"href":"https:\/\/www.noom.com\/uk\/wp-json\/wp\/v2\/b2b-topic?post=283963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}